These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 317434)

  • 41. Secondary immune defects in non-Hodgkin's lymphoma.
    Datta U; Kaur K; Varma SC; Bhaskar KV; Sehgal S
    Indian J Med Res; 1992 Apr; 96():91-5. PubMed ID: 1428071
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Primary non-Hodgkin's lymphoma of the brain, sarcoidosis, thyroid cancer and immunity cell deficiency (author's transl)].
    Trillet M; Pialat J; Chazot G; Bourrat C; Schott B
    Rev Neurol (Paris); 1982; 138(3):241-8. PubMed ID: 7051223
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Immunity and hypersensitivity in Hodgkin's lymphoma].
    Leoni P; Marchegiani G; Montillo M; Centurioni R; Montroni M; Danieli G
    Minerva Med; 1982 May; 73(20):1361-9. PubMed ID: 6210855
    [No Abstract]   [Full Text] [Related]  

  • 44. Cellular immune responses and lymphocyte populations in chronic hepatitis.
    Pár A; Bajtai G; Barna K; Ambrus M; Kovács M; Balázs M; Palka I; Szalók I
    Acta Med Acad Sci Hung; 1979; 36(1):31-43. PubMed ID: 316635
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Immunologic principles of allergic contact eczema].
    Knop J
    Hautarzt; 1984 Dec; 35(12):617-22. PubMed ID: 6335504
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Controlled study of unspecific cellular immunity in cancer patients].
    Dominioni L; Dionigi R; Prati U; Cividini F; Cincera M; Pavesi L; Della Cuna GR
    Minerva Med; 1981 Mar; 72(12):733-40. PubMed ID: 6971418
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interaction between serum factors and T lymphocytes in Hodgkin's disease. Use as a diagnostic test.
    Fuks Z; Strober S; Kaplan HS
    N Engl J Med; 1976 Dec; 295(23):1273-8. PubMed ID: 185517
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Cellular immunity indices in lymphogranulomatosis].
    Baĭsogolov GD; Pavlov VV; Konopliannikov AG; Kozlov VM; Kulish IuS
    Sov Med; 1981; (6):29-34. PubMed ID: 6974405
    [No Abstract]   [Full Text] [Related]  

  • 49. [T-T suppressor function induced by Con-A in patients with non-Hodgkin's lymphoma without previous treatment].
    Ruibal Ares B; Sasiain MD; Bachmann AE
    Medicina (B Aires); 1981; 41 Suppl():118-22. PubMed ID: 6212735
    [No Abstract]   [Full Text] [Related]  

  • 50. Immunodeficiency and prognosis in patients with non-Hodgkin's lymphomas.
    Lindemalm C; Biberfeld P; Björkholm M; Holm G; Johansson B; Mellstedt H; Nilsson B; Ost A
    Acta Radiol Oncol; 1985; 24(2):159-65. PubMed ID: 2988279
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Proportions and absolute count of T- and B-lymphocytes in peripheral blood and their blastic transformation induced by mitogens in splenectomized and non-splenectomized patients with Hodgkin's disease].
    Pluzańska A
    Acta Haematol Pol; 1978; 9(1):37-44. PubMed ID: 307325
    [TBL] [Abstract][Full Text] [Related]  

  • 52. B and T lymphocytes in Hodgkin's disease. Analysis at diagnosis and following therapy.
    Gajl-Peczalska KJ; Bloomfield CD; Sosin H; Kersey JH
    Clin Exp Immunol; 1976 Jan; 23(1):47-55. PubMed ID: 1083318
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Parameters of T cell mediated immunity to commensal micro-organisms in patients with chronic purulent rhinosinusitis: a comparison between delayed type hypersensitivity skin test, lymphocyte transformation test and macrophage migration inhibition factor assay.
    van de Plassche-Boers EM; Drexhage HA; Kokjé-Kleingeld M; Leezenberg HA
    Clin Exp Immunol; 1986 Dec; 66(3):516-24. PubMed ID: 3552334
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adoptive transfer of cell-mediated immunity to tuberculin using RNA from tuberculin-sensitive subjects.
    Han T; Pauly JL; Mittelman A
    Immunology; 1975 Jan; 28(1):127-32. PubMed ID: 1116867
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epstein-Barr virus, clinical symptomatology and immunodeficiency in non-Hodgkin's lymphoma patients.
    Fejes M; Mochanko K; Brezavscek D; Suárez A; Pavlovsky A; Bachmann AE
    Medicina (B Aires); 1981; 41 Suppl():137-40. PubMed ID: 6285121
    [No Abstract]   [Full Text] [Related]  

  • 56. Cellular and humoral immunity in non-Hodgkin's lymphoma: correlation of immunodeficiencies with clinicopathologic factors.
    Lapes M; Rosenzweig M; Barbieri B; Joseph RR; Smalley RV
    Am J Clin Pathol; 1977 Apr; 67(4):347-50. PubMed ID: 403757
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A study on cell-mediated immunity to gastrointestinal cancer.
    Yagawa H; Ogawa K; Mikami N; Ohtani Y; Sakakibara N
    Cell Mol Biol Incl Cyto Enzymol; 1981; 27(2-3):119-31. PubMed ID: 6975169
    [No Abstract]   [Full Text] [Related]  

  • 58. Cell-mediated immunity in Darier's disease.
    Henry JC; Padilla RS; Becker LE; Bankhurst AD
    J Am Acad Dermatol; 1979 Oct; 1(4):348-51. PubMed ID: 315968
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Delayed cutaneous hypersensitivity in children with severe multiple handicaps treated with phenytoin.
    Higashi A; Matsuda I; Sinosuka S; Ohtsuka H; Endo F; Maeda T; Ikeda T; Miyoshino S
    Eur J Pediatr; 1978 Dec; 129(4):273-8. PubMed ID: 152707
    [TBL] [Abstract][Full Text] [Related]  

  • 60. T-lymphocyte colonies in malignant disease.
    Sutherland DC; Dalton G; Wilson JD
    Lancet; 1976 Nov; 2(7995):1113-5. PubMed ID: 62950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.